http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009140753-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16 |
| filingDate | 2008-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009140753-A |
| titleOfInvention | COMPOUNDS |
| abstract | 1. The compound of formula (I) or its pharmaceutically acceptable salt! ! where R1 and R2 are each independently H, alkyl or haloalkyl; ! R3 and R4 each independently represents H, alkyl, haloalkyl or aryl; ! R5 is alkyl or cycloalkyl or cycloalkylalkyl, each of which may optionally be substituted with one or more OH groups; ! R6 is selected from cyclopropylamino, cyclopropylmethylamino, cyclobutylamino, cyclobutylmethylamino and! ! where one of X, Y and Z represents N, and the rest represent CR9; ! R7, R8 and each R9 independently represent H, alkyl or haloalkyl; where at least one of R7, R8 and each R9 is not N.! 2. The compound according to claim 1, where one of R1 and R2 is H, and the other is alkyl. ! 3. The compound according to claim 1, where one of R1 and R2 is H and the other is methyl, ethyl or isopropyl. ! 4. The compound according to claim 1, where R1 is ethyl, and R2 is N.! 5. The compound according to claim 1, where R3 and R4 each independently represents H, alkyl, halogenated or aryl, and where at least one of R3 and R4 is not N.! 6. The compound according to claim 1, where one of R3 and R4 is H, and the other is alkyl or halogenated. ! 7. The compound according to claim 1, where R3 is H and R4 is alkyl or haloalkyl. ! 8. The compound according to claim 1, where R3 is H and R4 is methyl. ! 9. The compound according to claim 1, where R6 is! ! 10. The compound according to claim 1, where Y is N.! 11. The compound of claim 10, where X is CH, Z is C-Me, and R7 is H, and R8 is Me. ! 12. The compound of claim 10, where X is CH, Z is C-Me, and R7 and R8 are both N.! 13. The compound of claim 10, where X is CH, Z is C-CF3, and R7 and R8 are both N.! 14. The compound according to claim 1, where X � |
| priorityDate | 2007-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 203.